- Introducing a device into commercial distribution for the first time
- Different intended use for a device already in commercial distribution
- Indicated by claims made for a device in labeling/advertising
- Note: Prescription use to over-the-counter use is a major change in intended use
3. Change to a device that could significantly affect its safety or effectiveness
- Burden is on you to decide whether a modification “could significantly affect safety or effectiveness.”
- If no submission, justification should be recorded in your change control records
510(K) is not required under following conditions.
•Device is not marketed or commercially distributed
–Example: clinical trials (regulated by 21 CFR 812)
•Distributor of another firm's U.S.-manufactured device
•Device is not manufactured by your company, but is marketed or commercially distributed by your company
–Labeling shall reveal connection with manufacturer: "Manufactured for Life-Tech" or "Distributed by Life-Tech"
•For repackager or relabeler, if labeling or condition of the device is not significantly changed
–Labeling must be same as 510(k): indications for use, warnings, contraindications
•Device in commercial distribution before 5/28/76
–Must be documented
Related Training - http://www.complianceonline.com/ecommerce/control/trainingFocus?product_id=701016&channel=priya
No comments:
Post a Comment